SIMG
ITCI

Sonora Investment Management Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Sonora Investment Management Group’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-80,763
Closed -$10.7M – 323
2025
Q1 		$10.7M Sell
80,763
-6,168
-7% -$769K 0.84% 43
2024
Q4 		$7.26M Sell
86,931
-953
-1% -$78.3K 0.56% 56
2024
Q3 		$6.43M Buy
87,884
+454
+0.5% +$34.1K 0.48% 65
2024
Q2 		$6.05M Hold
87,430
– – 0.47% 73
2024
Q1 		$6.05M Sell
87,430
-85
-0.1% -$5.84K 0.47% 73
2023
Q4 		$6.27M Sell
87,515
-328
-0.4% -$18.9K 0.51% 70
2023
Q3 		$4.58M Sell
87,843
-334
-0.4% -$19.5K 0.39% 82
2023
Q2 		$5.58M Sell
88,177
-2,919
-3% -$182K 0.47% 76
2023
Q1 		$4.93M Sell
91,096
-1,075
-1% -$52K 0.43% 80
2022
Q4 		$4.88M Buy
92,171
+2,177
+2% +$109K 0.44% 81
2022
Q3 		$5.14M Buy
89,994
+150
+0.2% +$7.84K 0.66% 58
2022
Q2 		$5.13M Sell
89,844
-700
-0.8% -$39.7K 0.49% 77
2022
Q1 		$5.54M Buy
90,544
+1,493
+2% +$77.5K 0.63% 60
2021
Q4 		$4.66M Buy
+89,051
New +$3.74M 0.54% 63

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Sonora Investment Management Group's ITCI Position: Q2 2025 in Review

Sonora Investment Management Group sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 80,763 shares — an estimated $10.7M sold.

Sonora Investment Management Group first reported a position in ITCI in Q4 2021 and held it in 14 quarters. The position peaked at $10.7M in Q1 2025. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Sonora Investment Management Group reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Sonora Investment Management Group sold 80,763 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $10.7M.
  • Sonora Investment Management Group first reported a position in Intra-Cellular Therapies Inc. in Q4 2021 and held it in 14 quarters.
  • Sonora Investment Management Group's Intra-Cellular Therapies Inc. position peaked at $10.7M in Q1 2025.
  • 3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Sonora Investment Management Group's 13F filing for Q2 2025, filed 17 Jul 2025.